The safety of methoxyflurane for emergency pain relief in children and adolescents: a retrospective cohort study
https://pubmed.ncbi.nlm.nih.gov/39212349/
Conclusions:
In children and adolescents transported by ambulance, the use of methoxyflurane was not associated with an increased risk of hospitalization, death, serious adverse drug reactions or liver and kidney toxicity.
Another Positive Study, page-163
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.005(1.11%) |
Mkt cap ! $51.25M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.0¢ | 44.0¢ | $19.9K | 44.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 44643 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 15.57pm 08/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |